Brief: EBR Systems Updates On Submission Of Final Module To FDA
15/11/2023 01:50
Nov 15 (Reuters) - EBR Systems Inc EBR.AX :
* UPDATE ON SUBMISSION OF FINAL MODULE TO FDA
* NOW EXPECTS TO SUBMIT FINAL MODULE FOR PMA SUBMISSION IN
Q3 2024
* NOW TARGETING FDA APPROVAL DURING Q1 2025
Source text for Eikon: ID:nASX1sz79r
Further company coverage: EBR.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on EBR Systems
See all newsAustralia's EBR Systems jumps on filing application for heart treatment
Brief: EBR Systems Submits TGA ARTG Application For Wise® System
Australia's EBR Systems hits record low on weak third-quarter revenue outlook
Brief: EBR Systems Forecasts Q3 2026 Revenue Of US$2.4 MLN To US$2.5 MLN
Brief: EBR Systems Announces Its Plan To Submit A Changes For Supplements To FDA In Q4 2026